STOK Stoke Therapeutics posts wider than expected Q4 2025 loss shares gain slightly despite steep earnings miss AdaptHealth AHCO Support Levels Q4 2025 Earnings Fall Short The technology investments behind abrdn Credit ACP growth How Equinox EQX is positioning for the next five years Mini Selloff 20260505